These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospects for new tuberculosis treatment in Africa. Mwinga A; Bernard Fourie P Trop Med Int Health; 2004 Jul; 9(7):827-32. PubMed ID: 15228494 [TBL] [Abstract][Full Text] [Related]
4. Shortening treatment for tuberculosis--to basics. Warner DF; Mizrahi V N Engl J Med; 2014 Oct; 371(17):1642-3. PubMed ID: 25337754 [No Abstract] [Full Text] [Related]
5. Response to short-course chemotherapy of patients with initial resistance to antituberculosis drugs. Valenzuela P; Valenzuela MT; Ponce J Bull Pan Am Health Organ; 1988; 22(2):175-83. PubMed ID: 3048504 [No Abstract] [Full Text] [Related]
6. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [TBL] [Abstract][Full Text] [Related]
7. Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India. Velayutham BV; Allaudeen IS; Sivaramakrishnan GN; Perumal V; Nair D; Chinnaiyan P; Paramasivam PK; Dhanaraj B; Santhanakrishnan RK; Navaneethapandian GP; Marimuthu MK; Kumar V; Kandasamy C; Dharuman K; Elangovan T; Narasimhan M; Rathinam S; Vadivelu G; Rathinam P; Chockalingam C; Jayabal L; Swaminathan S; Shaheed JM Clin Infect Dis; 2014 Nov; 59(10):e142-9. PubMed ID: 25028463 [TBL] [Abstract][Full Text] [Related]
8. [Respiratory fluoroquinolones and pulmonary tuberculosis treatment when the main drugs are ineffective]. Lazareva NB; Khaĭmenova TIu; Khaĭmenov AIa Antibiot Khimioter; 2008; 53(5-6):14-20. PubMed ID: 19069177 [No Abstract] [Full Text] [Related]
9. [Results of different programs of chemotherapy using rifampicin in patients with newly detected destructive pulmonary tuberculosis]. Sodikov ES; Abrarov BA Probl Tuberk; 1986; (5):27-30. PubMed ID: 3526322 [No Abstract] [Full Text] [Related]
10. [Clinical trials on chemotherapy of tuberculosis in Chile (author's transl)]. Farga V Rev Med Chil; 1981 Aug; 109(8):769-73. PubMed ID: 7043693 [No Abstract] [Full Text] [Related]
17. New tuberculosis therapy offers potential shorter treatment. Phase III trials planned in Africa. Saudi Med J; 2006 Apr; 27(4):573-4. PubMed ID: 16736564 [No Abstract] [Full Text] [Related]
18. [Results of two 6-month regimens in the treatment of pulmonary tuberculosis]. Sauret J; Heredia JL; Cornudella R Med Clin (Barc); 1987 Jun; 89(5):177-9. PubMed ID: 3626674 [No Abstract] [Full Text] [Related]
19. [The clinical and pharmacokinetic features of lymphotropic therapy in patients with new-onset pulmonary tuberculosis]. Priakhina VN; Kolpakov MA; Kolpakov AR; Zyrianova TV; Mokhina OG Probl Tuberk Bolezn Legk; 2005; (6):55-8. PubMed ID: 16078725 [TBL] [Abstract][Full Text] [Related]